Genosyl

Product manufactured by Vero Biotech Llc

Application Nr Approved Date Route Status External Links
NDA202860 None Respiratory (Inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Genosyl ® Is Indicated To Improve Oxygenation And Reduce The Need For Extracorporeal Membrane Oxygenation In Term And Near-Term (>34 Weeks Gestation) Neonates With Hypoxic Respiratory Failure Associated With Clinical Or Echocardiographic Evidence Of Pulmonary Hypertension In Conjunction With Ventilatory Support And Other Appropriate Agents. Genosyl ® Is A Vasodilator Indicated To Improve Oxygenation And Reduce The Need For Extracorporeal Membrane Oxygenation In Term And Near-Term (>34 Weeks Gestation) Neonates With Hypoxic Respiratory Failure Associated With Clinical Or Echocardiographic Evidence Of Pulmonary Hypertension In Conjunction With Ventilatory Support And Other Appropriate Agents ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nitric Oxide

Comments